Recent advances towards mass spectrometry-based clinical lipidomics




Salihovic Samira, Lamichane Santosh, Hyötyläinen Tuulia, Orešič Matej

PublisherElsevier Ltd

2023

Current Opinion in Chemical Biology

Current Opinion in Chemical Biology

102370

76

1879-0402

DOIhttps://doi.org/10.1016/j.cbpa.2023.102370

https://www.sciencedirect.com/science/article/pii/S1367593123001084?via%3Dihub

https://research.utu.fi/converis/portal/detail/Publication/180479017



The objective of this review is to provide a comprehensive summary of the latest methodological advancements and emerging patterns in utilizing lipidomics in clinical research.In this review, we assess the recent advancements in lipidomics methodologies that exhibit high levels of selectivity and sensitivity, capable of generating numerous molecular lipid species from limited quantities of biological matrices.

The reviewed studies demonstrate that molecular lipid signatures offer new opportunities for precision medicine by providing sensitive diagnostic tools for disease prediction and monitoring. Moreover, the latest innovations in microsampling techniques have the potential to make a substantial contribution to clinical lipidomics. The review also shows that more work is needed to harmonize results across diverse lipidomics platforms and avoid significant errors in analysis and reporting. The increased implementation of internal standards and standard reference materials in analytical workflows will aid in this direction.


Last updated on 2025-27-03 at 22:04